Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report

BACKGROUND: Anti-aminoacyl-tRNA synthetase (ARS) antibody-positive patients present with a variety of symptoms, including interstitial lung disease (ILD), which is termed anti-synthetase syndrome (ASS). But it is rare that ASS-ILD is considered an immune-related adverse event after the use of immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Ippei, Shimizu, Tetsuo, Kusahana, Ryo, Nomoto, Masayuki, Fujiwara, Daishi, Nishizawa, Tsukasa, Hayashi, Kentaro, Nakagawa, Yoshiko, Gon, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165749/
https://www.ncbi.nlm.nih.gov/pubmed/37158856
http://dx.doi.org/10.1186/s12890-023-02446-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165749/
https://www.ncbi.nlm.nih.gov/pubmed/37158856
http://dx.doi.org/10.1186/s12890-023-02446-z

Ejemplares similares